Investing

In this article Follow your favorite stocksCREATE FREE ACCOUNT Sanjeri | E+ | Getty Images Company: Fortrea Holdings (FTRE) Business: Fortrea Holdings is a global contract research organization, or CRO, that provides clinical development and patient access solutions to the life sciences industry. CROs work with drug companies through all stages of the drug development
0 Comments
In this article US10Y Follow your favorite stocksCREATE FREE ACCOUNT Bill Gross, Portfolio Manager, Janus Capital Group Lucy Nicholson | Reuters Widely followed investor Bill Gross believes Treasury yields have the potential to shoot even higher in the short run. “I think we’re gonna go to five [percent],” Gross said on CNBC’s “Last Call” Tuesday,
0 Comments
Bill Ackman, Pershing Square Capital Management CEO, speaking at the Delivering Alpha conference in NYC on Sept. 28th, 2023. Adam Jeffery | CNBC Billionaire investor Bill Ackman would “absolutely” do a deal with X, the social platform previously known as Twitter, with his newly approved investment vehicle, Ackman told The Wall Street Journal in a story
0 Comments
In this article FDX PINS CRM ADBE MSFT Follow your favorite stocksCREATE FREE ACCOUNT Shantanu Narayen, CEO, Adobe. Mark Neuling | CNBC Investors are grappling with uncertainty after a difficult September left the major averages reeling. However, the current scenario also offers an opportunity to pick stocks that could generate attractive returns despite short-term pressures.
0 Comments
In this article AZTA Follow your favorite stocksCREATE FREE ACCOUNT Choja | E+ | Getty Images Company: Azenta (AZTA) Business: Azenta is a life sciences company that operates through two segments. First, there’s the life sciences products division, which offers automated cold sample management systems for compound and biological sample storage, equipment for sample preparation
0 Comments
Bill Ackman, Pershing Square Capital Management CEO, speaking at the Delivering Alpha conference in NYC on Sept. 28th, 2023. Adam Jeffery | CNBC Billionaire investor Bill Ackman said Friday that U.S. regulators have approved his unique special purpose acquisition company structure, and he’s ready to hunt for a deal. Investors in Ackman’s unfruitful SPAC, known as
0 Comments